MIROMAVIMAB
UNII 420IGX81U4

Substance Identification & Data

This profile provides standardized clinical and technical data for Miromavimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 420IGX81U4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2247163-73-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

420IGX81U4

CAS Registry Number

2247163-73-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MIROMAVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175143

National Cancer Institute reference terminology for clinical and research data.

INN ID

11199

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Miromavimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MIROMAVIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-II) (MUS MUSCULUS MONOCLONAL M777-16-3 .GAMMA.1-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL M777-16-3 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(RABIES VIRUS STRAIN ERA (EVELYN-ROCKITNIKI-ABELSETH) GLYCOPROTEIN ECTODOMAIN EPITOPE G-II), MUS MUSCULUS MONOCLONAL ANTIBODY

MIROMAVIMAB [INN]

MIROMAVIMAB [WHO-DD]